Physician profile
David Robbins
NPI 1215024633
$941.23
in general payments reported to CMS, 2019-2025
12 companies · $180 in 2025
The $180 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $18.03 · 2021: $68.25 · 2022: $142 · 2023: $99.06 · 2024: $311 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $590.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $589.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $215.60 | 2021-2025 | Grafix Pl, Oasis |
| Stryker Corporation | $195.07 | 2020-2025 | Citrefix, Ortholoc 2 Lapifuse, Hoffmann |
| Treace Medical Concepts, INC. | $123.32 | 2024-2025 | |
| Wright Medical Technology, INC. | $123.12 | 2019 | |
| Paratek Pharmaceuticals, INC. | $75.40 | 2022-2025 | Nuzyra |
| Krystal Biotech INC | $61.62 | 2023-2025 | Vyjuvek |
| Nevro Corp. | $38.89 | 2022-2023 | Senza |
| Abbvie INC. | $32.78 | 2022 | |
| Medtronic, INC. | $27.35 | 2024 | Intellis Adaptivestim |
| Mimedx Group, INC. | $17.45 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $16.16 | 2023 | Seglentis |
| Bioventus LLC | $14.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Robbins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.